Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 397

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 397
---
 health indicators that align with customer needs and market trends. In addition, research projects are in progress that promise to introduce novel indicators and insights, with a view to further enrich our health reporting upon project completion. Concurrently, in pursuit of technical excellence, our data science team is further optimizing the precision of Rewell by developing a combination of machine learning models using several layers of datasets, derived from our users. This consented data includes genetic data, microbiome data, lifestyle data and other deep phenotyping datasets with integration of wearable analytics. Ultimately, the refinement of these models with several thousands of users datapoints will leverage an enhanced precision and better user experience in our goal to prevent disease development. 200 Scaling Nutritional Nutrigenetic Specialists The goal is to make the Rewell platform independent of a growing number of specialists that would increase linearly with the number of users, and thus increase costs. To achieve this, we are exploring various machine learning models and LLMs for automatic customer segmentation, generation of recommendations, and habit planning, which can be curated by the nutrigenetic specialists. We are developing AI Agents using LLM technology to assist users within the platform, and designing solutions that leverage the entire set of user information (genetic, microbiome, habit questionnaires) to enhance the sense of personalization. These initiatives reflect our dedication to delivering superior and actionable health analytics, fostering a deeper engagement with our users, and maintaining our commitment to innovation in the field of genomic health. Heritas Reproductive Genetics: Carrier Screening This product would implement carrier genetic testing to complement and strengthen our portfolio in the field of reproductive genetics. Carrier testing is an important genetic test when planning a family because it helps to determine the risk of having a child with a genetic disease. It determines if a user and their partner or donor are carriers of single -generecessive conditions. In addition, if a user and their partner, or donor, both carry the same mutation, the probability of having a sick child is 25%. Through this project, we would be able to combine all reproductive genetic tests in an all -in -onegenetic test solution, which includes carrier screening to prenatal testing, aimed at couples planning a family. Reproductive Genetics: PGT-A This initiative would implement preimplantation genetic testing to complement and further strengthen the portfolio of solutions of our reproductive genomics portfolio. PGT -Ais a genetic test performed on embryos to identify numerical chromosomal abnormalities (aneuploidy), which are detected prior to embryo transfer to